Skip to main content
editorial
. 2011 Jul 14;17(26):3075–3081. doi: 10.3748/wjg.v17.i26.3075

Figure 1.

Figure 1

Dynamic gadolinium-enhanced magnetic resonance imaging (MRI; T1, T2 weighting), in a 67 year old patient with hepatocellular carcinoma evolved from liver cirrhosis due to hemochromatosis (A) before initiation of anti-angiogenic therapy and (B) after 70 d or three cycles of transarterial chemoembolization and continuous administration of sorafenib, respectively. Patient showed partial response according to RECIST criteria. Serum alfa-fetoprotein level decreased from 276 to 115 ng/mL.